Form 8-K - Current report:
SEC Accession No. 0001104659-25-063601
Filing Date
2025-06-27
Accepted
2025-06-27 16:00:50
Documents
14
Period of Report
2025-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519053d1_8k.htm   iXBRL 8-K 33732
2 EXHIBIT 3.1 tm2519053d1_ex3-1.htm EX-3.1 6350
3 EXHIBIT 99.1 tm2519053d1_ex99-1.htm EX-99.1 5913
  Complete submission text file 0001104659-25-063601.txt   221361

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA snpx-20250626.xsd EX-101.SCH 3020
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20250626_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20250626_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2519053d1_8k_htm.xml XML 3927
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
TAO Synergies Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 251086137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)